These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8957552)

  • 81. Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining.
    Kato T; Fujita M; Sawamura Y; Tada M; Abe H; Nagashima K; Nakamura N
    Noshuyo Byori; 1996 Nov; 13(2):99-105. PubMed ID: 8958514
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Proliferating cell nuclear antigen in needle biopsy specimens of prostatic carcinoma.
    Naito S; Sakamoto N; Kotoh S; Goto K; Koga H; Hasegawa S; Matsumoto T; Kumazawa J
    Eur Urol; 1994; 26(2):164-9. PubMed ID: 7525294
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
    Zhou G; Lin D; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Fixation requirements for the immunohistochemical reactivity of PCNA antibody PC10 on cryostat sections.
    Baum HP; Reichrath J; Theobald A; Schock G
    Histochem J; 1994 Dec; 26(12):929-33. PubMed ID: 7896568
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
    Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
    Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation of proliferating cell nuclear antigen (PCNA) in supraglottic carcinoma.
    Liu M; Lawson G; Delos M; Jamart J; Remacle M
    Acta Otorhinolaryngol Belg; 1997; 51(3):129-35. PubMed ID: 9350310
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study.
    Ojanguren I; Ariza A; Llatjós M; Castellà E; Mate JL; Navas-Palacios JJ
    Hum Pathol; 1993 Aug; 24(8):905-8. PubMed ID: 7690737
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining.
    Kobayashi I; matsuo K; Ozeki S; Ohishi M; Ishibashi Y; Sakai H
    Hum Pathol; 1995 Aug; 26(8):907-13. PubMed ID: 7635453
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immunohistochemical localization of p53, PCNA, and TGF-alpha proteins in formaldehyde-induced rat nasal squamous cell carcinomas.
    Wolf DC; Gross EA; Lyght O; Bermudez E; Recio L; Morgan KT
    Toxicol Appl Pharmacol; 1995 May; 132(1):27-35. PubMed ID: 7747282
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.
    Xing Y; Ning Y; Ru LQ; Wang LD
    World J Gastroenterol; 2003 Jul; 9(7):1601-3. PubMed ID: 12854173
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
    Hasegawa H; Kusumi Y; Asakawa T; Maeda M; Oinuma T; Furusaka T; Oshima T; Esumi M
    BMC Cancer; 2017 May; 17(1):381. PubMed ID: 28549422
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Apoptosis index is a predictor of metastatic phenotype in patients with early stage squamous carcinoma of the tongue: a hypothesis to support this paradoxical association.
    Naresh KN; Lakshminarayanan K; Pai SA; Borges AM
    Cancer; 2001 Feb; 91(3):578-84. PubMed ID: 11169941
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prognostic value of proliferating cell nuclear antigen immunostaining in pediatric rhabdomyosarcomas.
    Tokuç G; Doğan O; Ayan I; Kebudi R; Doğan S; Demiryont M; Camlica H
    Acta Paediatr Jpn; 1998 Dec; 40(6):573-9. PubMed ID: 9893293
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 97. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
    Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
    Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Letter to the editor, "Personal immune profiles: Diversity and prognostic values for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.".
    Madhumitha M; Dharmalingam Jothinathan MK
    Oral Oncol; 2024 Aug; 155():106872. PubMed ID: 38839479
    [No Abstract]   [Full Text] [Related]  

  • 99. PCNA Staining of Retinal Cryosections to Assess Microglial/Macrophage Proliferation.
    Lovel AG; Mitchell DM
    Methods Mol Biol; 2023; 2636():389-400. PubMed ID: 36881312
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Constitutive activation of activator protein-1 as a cellular switch and its innovative role in the development of molecular targets for tongue squamous cell carcinoma treatment.
    Saravanan M
    Oral Oncol; 2022 Dec; 135():106198. PubMed ID: 36244258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.